Category: Health

Seoul, July 2: South Korea’s pharmaceutical exports have surpassed $10 billion for the first time in 2025, marking a major milestone for the country’s healthcare and biotechnology sector.

The strong performance has been driven by rising global demand for biosimilars, vaccines, and advanced drug formulations developed by South Korean companies. Industry experts say increased overseas approvals and expanded production capacity have also contributed to the growth.

Officials and analysts view this achievement as a sign of South Korea’s growing competitiveness in the global pharmaceutical market, with expectations of continued expansion in the coming years.

University of Toyama researchers find three factors that predict mother-to-infant bonding difficulties in the absence of postnatal depression

July 1: Mother-to-infant bonding difficulties (MIBD) are commonly associated with postnatal depression. MIBD has been linked to developmental delays and child abuse. Researchers found that about half of MIBD cases in Japan involve mothers who did not experience postpartum depression. Difficulty holding a fussy baby, lack of happiness about pregnancy, and low social support predict an increased risk of MIBD. Clinicians observing these signs should intervene to ensure maternal and child well-being.

  A strong emotional bond between a mother and her child is vital during early infancy. However, some mothers experience indifference, aloofness, or anger when interacting with their infants, a phenomenon called mother-to-infant bonding difficulties (MIBD). MIBD has been linked to inappropriate child-rearing and developmental delays in children. Therefore, it becomes crucial for medical professionals to intervene and help mothers bond better with their infants.

Researchers have long known that postnatal depression is a strong predictor of MIBD. However, mothers without postnatal depression make up a very large proportion of mother-child pairs affected by MIBD. “The prevalence of MIBD is reported to be 11%–12%, but to our knowledge, there are relatively few reports on the prevalence of MIBD without postnatal depression,” says Ms. Hitomi Inano from the Department of Nursing Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Japan. “It is highly likely that maternal bonding difficulties are involved in the steadily increasing incidence of child abuse and developmental disorders in recent years,” she adds.

Ms. Inano led a study on MIBD in mothers without postnatal depression. This study was supported by Dr. Akiko Tsuchida, Dr. Hidekuni Inadera, and Professor Tomomi Hasegawa from the Faculty of Medicine at the University of Toyama, as well as Dr. Kenta Matsumura from the Aomori University of Health and Welfare. Using data from the Japan Environment and Children’s Study (JECS), the researchers studied the overall prevalence of MIBD and factors associated with increased MIBD risk. Their findings were made available online on June 3, 2026, in Volume 29 of the journal Archives of Women’s Mental Health.

The research team found that MIBD was present in 11.6% of all mother-child pairs in the JECS dataset, which was consistent with previous studies. While MIBD prevalence was only 7.7% in mother-child pairs where the mother did not have postnatal depression, this group still accounted for nearly half of all cases of MIBD in the dataset. Next, the team looked at the prevalence of the two components of MIBD, namely lack of affection (LA) and anger and rejection (AR). 38.2% of mothers gave at least one affirmative response to LA-related items, compared with 51.8% for AR-related items.

What aspects of pregnancy and postpartum increase the risk of MIBD? The team analyzed 30 variables across six dimensions: child factors, maternal physical factors, maternal lifestyle factors, maternal psychological factors, maternal social and economic factors, and healthcare or medical intervention factors. Of these, three variables showed the strongest associations with MIBD.

 The strongest predictor was a mother reporting difficulty in holding her infant due to crying, fussiness, or back-arching at one month postpartum; these mothers were 3.45 times more likely to experience MIBD at one year postpartum. The second strongest predictor was a mother reporting any emotion other than happiness upon pregnancy confirmation—confusion, upset, or neutrality were associated with a 2.42-fold increase in MIBD risk. Conversely, mothers reporting high social support during their pregnancy had a 55% lower likelihood of experiencing MIBD.

Ms. Inano highlights the need for active monitoring and intervention. “Mothers with bonding difficulties who screen negative for postnatal depression are unlikely to be identified by healthcare professionals and are therefore often overlooked as potential recipients of support,” she says. Clinicians should strongly consider intervening if a mother reports difficulty in handling her baby when the baby is cranky or arching their back, even if the mother shows no signs of postnatal depression.

Ms. Inano hopes that these findings will lead to more mothers receiving timely support, thus ensuring their own well-being and the healthy development of their children.

A genomic study links rare inherited BRCA2 mutations to primary lungadenocarcinomas

Although lung cancer is often linked to environmental exposures and acquired mutations, some patients develop multiple independent tumors, suggesting a potential role for inherited genetic susceptibility. While the contribution of germline pathogenic variants (GPVs) in several tumors is studied, their significance in lung cancer remains unknown. Now, researchers have explored the genetic basis of multiple primary lung cancers, offering  insights into novel BRCA2 GPVs which could serve as targets for therapeutic strategies.

Lung cancer remains the leading cause of cancer-related deaths worldwide and is generally thought to arise from mutations acquired over a lifetime through environmental exposures. However, clinicians are increasingly encountering patients with not just one, but multiple tumors in their lungs. At Fujita Health University Hospital in Japan, 7.5% (53/699 cases)of lung cancer surgeries involved patients with synchronous or metachronous multiple lung lesions, far more than would be expected. Whether these additional tumors represented cancer spreading within the lungs or reflected an inherited predisposition to developing multiple independent cancers remains unclear.

To explore this, a team of researchers led by Professor Motoshi Suzuki from the Department of Molecular Oncology, Fujita Health University, Japan, along with a graduate student Dat Quoc Tran from the Department of Molecular Oncology, Fujita Health University, Japan, employed genomic sequencing techniques. They hypothesized that hidden genetic factors, rather than chance alone, might explain at least some of these cases. Their findings were published in Volume 34 Issue 6 of the journal Oncology Researchon May 21, 2026.

“Although germline pathogenic variants (GPVs) have transformed the understanding and management of some cancers, their role in lung adenocarcinoma(LUAD) has remained largely unexplored,” says Prof. Suzuki.

The researchers analyzed 26 LUADtumors from 11 patients with multiple lung cancers using targeted next-generation sequencing covering 143 cancer-related genes. By comparing mutation profiles across tumors and validating shared variants with Sanger sequencing, they distinguished inherited germline variants from tumor-acquired mutations. To determine whether similar alterations occurred more broadly, they also screened 125 tumors from an independent cohort of 123 patients withLUAD.

The results revealed that nine of the 11 patients had true multiple primary lung cancers, while one had intrapulmonary metastasis and one exhibited features of both conditions, underscoring the value of combining genomic profiling with conventional pathology for accurate diagnosis. More strikingly, the researchers identified two previously unreported truncating germline variants inBRCA2. One was detected across three independent tumors in a single patient, while the second was found in an unrelated patient who lacked the common driver mutations typically associated withLUAD. These findings suggest that inherited BRCA2 alterations may contribute to susceptibility to multiple primary lung cancers.

The study also points toward important clinical applications. Molecular profiling could help physicians distinguish multiple primary tumors from intrapulmonary metastases, enabling more accurate staging and treatment decisions. Furthermore, identifying inherited BRCA2 alterations raises the possibility that some patients may benefit from therapies already used for other BRCA-associated cancers. “We identified BRCA2 likely GPVs in patients with multiple primary LUAD. Thus, PARP inhibitors and other molecularly targeted approaches directed at BRCA2-related DNA repair deficiencies may eventually become viable treatment options for patients with these specific genetic backgrounds,”says Prof. Suzuki.

Overall, the study provides compelling evidence that inherited genetic susceptibility may contribute to the development of primaryLUAD. By uncovering two novel likely pathogenic BRCA2 variants and demonstrating the power of integrated genomic profiling, the research opens new avenues for precision diagnosis, targeted therapy, and future efforts to identify and manage patients at increased genetic risk.

New Delhi, June 30: BJP National President JP Nadda has lauded Prime Minister Narendra Modi’s vision and leadership in strengthening India’s health sector and medical education ecosystem.

He said that under the Prime Minister’s leadership, the country has witnessed significant expansion in healthcare infrastructure, including an increase in medical colleges, medical seats, and improved access to quality healthcare services.

Nadda noted that ongoing reforms have helped modernise the medical education system, improve healthcare delivery, and address the shortage of trained medical professionals across the country.

He further stated that these initiatives are contributing to a stronger, more resilient health system capable of meeting the country’s growing healthcare needs.

The BJP reiterated its commitment to supporting continued reforms and development in the health and medical education sectors under the leadership of Prime Minister Narendra Modi.

Combining whole genome interpretation with large-scale whole-body MRI to enable a more comprehensive view of human health 

San Diego, CA — June 30, 2026 — Simplify Genomics today announced a collaboration with SimonMed aimed at advancing a more integrated approach to preventive healthcare. By combining SimonMed’s national scale in whole-body MRI with Simplify’s Whole Genome Interpretation and Reporting Platform, the collaboration seeks to provide a more complete picture of human health— helping identify risk earlier, personalize care pathways, and support more proactive health decisions. Across both imaging and genomics, there is growing evidence that early indicators associated with disease may be identified well before they surface in traditional care pathways. Together, these modalities offer complementary perspectives: genomics can provide insight into underlying disease risk, while imaging can help identify existing structural or physiological changes. 

Simplify Genomics has spent years developing and refining its clinical reporting platform as a CAP/CLIA-certified laboratory and has processed in excess of 50,000 whole genomes to date. The platform includes thousands of disease associations and a broad set of pharmacogenomic insights, designed to support clinical interpretation and integration within real-world care settings. 

Paired with SimonMed’s leadership in accessible, AI-enhanced imaging at national scale—including a network of more than 175 imaging centers across the United States —the collaboration creates an opportunity to explore patterns and connections that may not be visible through any single modality alone, supporting earlier insight and helping to inform clinical decision-making. 

“This collaboration reflects a shared vision for the future of healthcare—one that is more proactive, data-driven, and personalized,” said Travis Lacey, CEO of Simplify Genomics. 

“We believe the future of healthcare lies in making advanced preventive insights more accessible and actionable,” said John Simon, CEO of SimonMed. “By combining imaging and genomics, we have an opportunity to help patients and providers better understand health risk earlier and with greater clarity.” The collaboration is progressing rapidly, with additional updates expected in the near future. 

June 29: Union Health Minister J.P. Nadda has launched the Ayushman Sarathi WhatsApp chatbot along with a Unified Drug Registry to make healthcare services more accessible and digitally connected.

The WhatsApp chatbot will help citizens easily access information about government health schemes, hospital services, eligibility, and other health-related queries in a simple and quick way.

The Unified Drug Registry will act as a central digital system to track medicines and improve their availability, monitoring, and regulation across the healthcare system.

Officials said the initiative aims to make healthcare services more transparent, efficient, and citizen-friendly by using widely accessible digital platforms.

June 29: The government has invited proposals from industry, startups, academic institutions, research organisations, and innovators to reduce India’s dependence on imported medical devices and strengthen the country’s domestic manufacturing ecosystem.

The initiative aims to identify practical solutions that can accelerate indigenous production, promote innovation, and address critical technology gaps in the medical devices sector. It seeks to encourage the development of high-quality, affordable medical equipment that can meet India’s growing healthcare needs while reducing reliance on overseas suppliers.

Officials said the proposals will help shape policies and support mechanisms to strengthen research and development, encourage investment in advanced manufacturing, and foster collaboration between industry, academia, and government. The move is also expected to improve supply chain resilience, enhance India’s competitiveness in the global medical devices market, and create new opportunities for startups and manufacturers.

The initiative forms part of the government’s broader vision of building a self-reliant healthcare ecosystem under the Atmanirbhar Bharat initiative, ensuring reliable access to critical medical technologies while positioning India as a global hub for medical device innovation and manufacturing.

New Delhi, June 2026: The Government of India is set to launch Aarogya Setu 2.0, along with a series of new digital health initiatives aimed at strengthening inclusive and accessible healthcare across the country.

The upgraded platform will focus on providing citizens with enhanced health tracking, real-time medical alerts, telemedicine support, and improved integration with government health services. Officials said the new version will be more user-friendly, secure, and connected with India’s expanding digital health ecosystem.

Alongside Aarogya Setu 2.0, the government is also rolling out additional digital initiatives designed to improve health data management, early disease detection, and access to healthcare services in rural and underserved areas.

Health authorities stated that these initiatives are part of a broader mission to build a digitally empowered and inclusive healthcare system, ensuring better reach, faster response, and improved public health outcomes.

The launch is expected to significantly strengthen India’s digital health infrastructure and support the goal of universal healthcare access.

Chennai, June 27: Chief Minister Vijay will launch a statewide Pulse Polio Immunization Campaign in Tamil Nadu on Sunday, reinforcing the government’s commitment to sustaining polio-free status and strengthening child health initiatives across the state.

The campaign aims to ensure 100% immunization coverage for children under the age of five through widespread vaccination drives at hospitals, primary health centres, schools, and designated booths across all districts.

State health officials have made extensive preparations, including setting up immunization booths, mobilizing healthcare workers, and coordinating with local administration to ensure smooth implementation of the drive. Awareness campaigns have also been intensified to encourage maximum participation from parents and guardians.

The Pulse Polio initiative remains a critical public health program, focusing on preventing the re-emergence of poliovirus and maintaining high levels of community immunity. The state government continues to prioritize child health and preventive healthcare through regular immunization efforts.

The Chief Minister’s participation in the launch event underscores the administration’s focus on strengthening public health infrastructure and ensuring the well-being of children across Tamil Nadu.